Skip to main content

Advertisement

SpringerLink
Log in

Implantable Dual-Chamber Defibrillator for the Selective Treatment of Spontaneous Atrial and Ventricular Arrhythmias: Arrhythmia Incidence and Device Performance

  • Published:
Journal of Interventional Cardiac Electrophysiology Aims and scope Submit manuscript

Abstract

Introduction: Atrial tachyarrhythmias are a common co-morbidity in patients with an ICD indication. Recently introduced ICD’s are equipped to independently detect and treat atrial and ventricular tachyarrhythmias. The purpose of this prospective study was to evaluate the incidence and termination of spontaneous atrial and ventricular tachyarrythmias in patients with a history of atrial tachyarrhythmias.

Methods and Results: Ninety patients, 70% male with an ICD indication and history of atrial tachyarrhythmia (LVEF 45 ± 6%, [AT/AF indication 55 ± 10, AT/VT 45 ± 16], 46% CAD) were enrolled and 89 were implanted with a VENTAK PRIZM AVT (Guidant). Spontaneous atrial and ventricular tachyarrhythmias were printed and evaluated during an average follow-up period of 272 ± 72 days utilizing the stored intracardial electrogram function of the device. Nineteen patients (21%) presented had only atrial tachyarrhythmias, 32 patients (36%) had both atrial and ventricular tachyarrhythmias and 18 patients (20%) had only ventricular tachyarrhythmias. Patients with only atrial tachyarrhythmias had a total of 3274 atrial episodes; 2002 terminated spontaneously, 1264 were treated with ATP and 8 with shock therapy. ATP was successful in 735 (58%) of 1264 episodes. Patients with both atrial and ventricular tachyarrhythmias had 7277 documented atrial tachyarrhythmias, 5231 terminated spontaneously, 1153 of 2009 were terminated by ATP (57.4%) and 37 by shock therapy (20 patient controlled). Atrial tachyarrhythmias identified as atrial flutter (AT) by the atrial rhythm classification (ARC) algorithm had a higher ATP conversion success rate than episodes identified as atrial fibrillation (AF); 66.7% for AT and 26.4% for AF. Patients with only ventricular tachyarrhythmias had 690 documented episodes, 401 terminated spontaneously, 248 (85.8%) were terminated by ATP and 41 by shock.

Conclusion: Seventy-seven percent of patients with an ICD indication had spontaneous atrial and/or ventricular tachyharrhythmias within the first 6 months after ICD implantation. ATP therapy terminated 58% of all atrial tachyarrhytmias and 66.7% of the atrial flutters. The dual chamber ICD detected, classified and terminated all ventricular tacharrhythmias appropriately.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Levy S, Breithardt G, Campbell RW, Camm AJ, Daubert JC, Allessie M, Aliot E, Capucci A, Cosio F, Crijns H, Jordaens L, Hauer RN, Lombardi F, Luderitz B. Atrial fibrillation: Current knowledge and recommendations for management. Eur Heart J 1998;19:1294–1320.

    Google Scholar 

  2. Boriani G, Biffi M, Martignani C, Luceri R, Bartolini P, Branzi A. Current clinical perspectives on implantable devices for atrial fibrillation. Curr Opin Cardiol 2002;17:82–89.

    Google Scholar 

  3. Jung W, Wolpert C, Esmailzadeh B, Spehl S, Herwig S, Schumacher B, Lewalter T, Omran H, Schimpf R, Vahlhaus C, Welz A, Luderitz B. Clinical experience with implantable atrial and combined atrioventricular defibrillators. J Interv Card Electrophysiol 2000;4(Suppl. 1):185–195.

    Google Scholar 

  4. Gold MR, Sulke N, Schwartzman DS, Mehra R, Euler DE; Worldwide Jewel AF-Only Investigators. Clinical experience with a dual-chamber implantable cardioverter defibrillator to treat atrial tachyarrhythmias. J Cardiovasc Electrophysiol 2001;12:1247–1253.

    Google Scholar 

  5. Birnie D, Tang A, Green M, Lemery R. Efficacy of atrial pacing therapies for atrial tachyarrhythmias in patients with a dual chamber implanatble cardioverter defibrillator. PACE 2003;26(4):1014.

    Google Scholar 

  6. Disertori M, Padeletti L, Santini M, et al. Antitachycardia pacing therapies to terminate atrial tachycardias: The AT500 Italian Registry. Eur Heart J 2001;3(Suppl. P) P16–P24.

    Google Scholar 

  7. Adler SW 2nd, Wolpert C, Warman EN, Musley SK, Koehler JL, Euler DE. Efficacy of pacing therapies for treating atrial tachyarrhythmias in patients with ventricular arrhythmias receiving a dual-chamber implantabel cardioverter defibrillator. Circulation 2001;104:887–892.

    Google Scholar 

  8. Grönefeld DC, Mauss O, Li Yg, Klingenheben T, Hohnloser SH. Association between atrial fibrillation and appropriate implantable cardioverter defibrillator therapy: Results from a prospective study. J Cardiovasc Electrophysiol 2000;11:1208–1214.

    Google Scholar 

  9. Israel CW, Ehrlich JR, Grönefeld G, et al. Prevalence, characteristics and clinical implications of regular atrial tachyarrhythmias in patients with arial fibrillation. J Am Coll Cardiol 2001;38:355–363.

    Google Scholar 

  10. Boriani G, Wollmann C, Biffi M, Kuhl M, Schuchert A, Sperzel J, Stiller S, Gasparini G, Bocker D. Evaluation of a dual chamber implantable cardioverter defibrillator for the treatment of atrial and ventricular arrhythmias. PACE 2003;26(Pt. III):461–465.

    Google Scholar 

  11. Boriani G, Biffi M, Padeletti M, et al. Effects of consistent atrial pacing and atrial rate stabilization–-two pacing algorithms to suppress recurrent paroxysmal atrial fibrillation in brady—tachy syndrome. Eur Heart J 2001;3(Suppl. P):P7–P15.

    Google Scholar 

  12. Benser ME, Walcott GP, Killingsworth CR, Girouard SD, Morris MM, Ideker RE. Atrial defibrillation thresholds of electrode configurations available to an atrioventricular defibrillator. J Cardiovasc Electrophysiol 2001;12:957–964.

    Google Scholar 

  13. Cooklin M, Olsovsky MR, Brockman RG, Shorofsky SR, Gold MR. Atrial defibrillation with a transvenous lead. J Am Coll Cardiol 1999;34:358–362.

    Google Scholar 

  14. Gillis AM, Unterberg-Buchwald C, Schmidinger H, Santini M, Wolfe K, Kavaney DJ, Otterness MF, Hohnloser SH. Safety and efficacy of advanced atrial pacing therapies for atrial tachyarrhythmias in patients with a new implantable dual chamber cardioverter-defibrillator. J AM Coll Cardiol 2002;40(9):1653–1659.

    Google Scholar 

  15. Hobbs FDR, Jones MI, Allan TF, Wilson S, Tobias R. European survey of primary care physician perceptions on heart failure diagnosis and management (Euro-HF). European Heart Journal 2000;21:1877–1887.

    Google Scholar 

  16. Bellotti P, Badano, LP, Acquarone N, Griffo R, Lo Pinto G, Maggioni AP, Mattiauda C, Menardo G, Mombelloni P, for the OSCUR investigators. Specialty-related differences in the epidemiology, clinical profile, management and outcome of patients hospitalized for heart failure. The OSCUR study. European Heart Journal 2001;22:596–604.

    Google Scholar 

  17. Cleland JGF, Cohen-Solal A, Cosin Aguilar J, Dietz R, Eastaugh J, Follath F, Freemantle N, Gavazzi A, van Gilst WH, Hobbs FDR, Korewicki J, Madeira HC, Preda I, Swedberg K, Widimsky J, for the IMPROVEMENT of Heart Failure. Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): An international survey. Lancet 2002;360:1631–1639.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Hamburg, Germany

    Andreas Schuchert (MD)

  2. Institute of Cardiology, University of Bologna, Italy

    Giuseppe Boriani & Mauro Biffi

  3. Department of Cardiology, University of Münster, Germany

    Christian Wollmann & Dirk Böcker

  4. Guidant Europe, Belgium

    Martin Kühl

  5. Bad Nauheim, Germany

    Johannes Sperzel

  6. University of Ulm, Germany

    Sascha Stiller

  7. Mestre Hospital, Italy

    Gianni Gasparini (on behalf of the VENTAK PRIZM AVT Investigators)

  8. Department of Cardiology, University of Hamburg, Martinistr. 11, 20253, Hamburg, Germany

    Andreas Schuchert (MD)

Authors
  1. Andreas Schuchert
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Giuseppe Boriani
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Christian Wollmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mauro Biffi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Martin Kühl
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Johannes Sperzel
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Sascha Stiller
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Gianni Gasparini
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Dirk Böcker
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andreas Schuchert.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schuchert, A., Boriani, G., Wollmann, C. et al. Implantable Dual-Chamber Defibrillator for the Selective Treatment of Spontaneous Atrial and Ventricular Arrhythmias: Arrhythmia Incidence and Device Performance. J Interv Card Electrophysiol 12, 149–156 (2005). https://doi.org/10.1007/s10840-005-6551-5

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10840-005-6551-5

Key words

Search

Navigation